Animal Welfare Group Sues ARMRA Over Health and Sourcing Claims

What Happened

Animal Partisan has filed a lawsuit against Rahal Biosciences, the maker of the popular bovine colostrum supplement ARMRA. The legal action, initiated in Washington, D.C., alleges the company uses deceptive marketing regarding both product efficacy and animal welfare standards.

The complaint challenges ARMRA’s health claims, asserting that the company lacks peer-reviewed clinical data to support promises about immune, metabolic, and skin health. Furthermore, the suit cites laboratory testing that allegedly contradicts the brand's product purity labeling.

The lawsuit also targets the company's ethical marketing. It claims that assertions regarding the humane treatment of dairy cows and the sourcing of surplus colostrum are unsubstantiated, arguing that the brand fails to provide transparency regarding its partner farms.

The Core Points

Nonprofit Animal Partisan filed a lawsuit against Rahal Biosciences over ARMRA marketing.
Plaintiffs allege a lack of peer-reviewed human clinical trials to support health claims.
Laboratory tests purportedly show discrepancies between product ingredients and label claims.
The suit challenges the company's depiction of its farming practices and animal welfare.
The legal action seeks to stop allegedly deceptive business practices in the supplement industry.

Context in 60 Seconds

The bovine colostrum market has grown into a billion-dollar industry, capitalizing on consumer interest in immunity and gut-health supplements. Because the FDA classifies these products as supplements, they face less rigorous oversight than pharmaceuticals, leaving the door open for aggressive and potentially misleading marketing tactics.

This case reflects a broader trend of nonprofit organizations utilizing consumer protection laws to challenge animal agricultural practices. By targeting the marketing claims of high-growth wellness brands, these groups aim to force greater transparency in supply chains that have historically operated with minimal public scrutiny.

Bottom Line

The lawsuit aims to hold the manufacturer accountable for its health and welfare claims, potentially setting a legal precedent for transparency in the rapidly expanding supplement sector.

Loading briefing details...